Hungary
Industry
The 12% tax that drug manufacturers pay on revenues for reimbursed drugs in Hungary is to stay, and there will be a push to reintroduce the annual HUF5mn (US$29,958) registration...
2008-09-15Industry
Hungary's Egis - like domestic rival Gedeon Richter - is having to deal with external pressures on both the domestic and foreign fronts in 2008, as sales for Q208 (FYQ3) dropped 5%...
2008-08-14Industry
US pharmaceutical giant Pfizer is looking to build a new R&D centre in Central and Eastern Europe (CEE), with Hungary one of the key contenders. According to the head of Pfizer's...
2008-08-05Industry
Hungary's national health insurance fund (OEP) is set to make a profit of up to HUF10bn (US$67mn) in 2008, according to health minister Tamás Székely. Although this suggests that...
2008-08-04Industry
Gedeon Richter has unveiled plans to build a HUF15bn (US$101mn) biotechnology plant in Debrecen, Eastern Hungary. Construction of the new plant - said to be unique in Central and...
2008-07-24Companies
Puls Biznesu reported that the merger agreement between Polpharma and Gedeon Richter failed after Polpharma's parent Genefar pulled out of their merger agreement.
2008-07-10Industry
Sales for Wyeth's Prevenar PCV7 (7-valent pneumococcal saccharide conjugated vaccine) are to be given a boost after it was added to national immunisation programmes in six countries...
2008-07-10Companies
Hungary's Gedeon Richter has been given the green light from Poland's Office of Competition and Consumer Protection (OCCP) for the acquisition of Polish generics maker Polpharma....
2008-07-07Industry
In a judgment that will allow Hungarian pharmaceutical companies to reduce their sales-related costs significantly, the Constitutional Court has ruled that the current high tax on...
2008-06-20Companies
US drugmaker Mylan has exercised its option to acquire Merck KGaA's Central and Eastern Europe (CEE) generics business, expanding its European footprint and gaining access to high...
2008-06-03




